Are Nicotine Pouches Safe Long Term? An Honest Look at the Evidence

This is the question everyone using nicotine pouches eventually asks, and there’s no clean, simple answer. Not because the evidence is scary, but because nicotine pouches haven’t existed long enough for us to have 20- or 30-year studies on users. That’s just the reality.

What I can do is walk you through what we actually know, what the best available proxy data tells us, where the FDA currently stands, and where the genuine unknowns are. I’m going to be honest about all of it, including the parts where the answer is “we don’t know yet.”

First, Let’s Separate Nicotine From Smoking

This is the most important concept in this entire discussion, and it’s one that most people get wrong.

Smoking kills approximately 480,000 Americans every year. But it’s not the nicotine doing the killing. It’s the combustion. When you burn tobacco and inhale the smoke, you’re taking in over 7,000 chemicals, including at least 70 known carcinogens. Carbon monoxide, tar, formaldehyde, benzene, arsenic. That’s what causes lung cancer, emphysema, heart disease, and stroke.

Nicotine itself is an addictive stimulant. It raises your heart rate and blood pressure temporarily. It’s not harmless. But it’s not the primary driver of smoking-related disease. The Royal College of Physicians in the UK put it well: “nicotine itself is not especially dangerous.”

This matters because nicotine pouches contain nicotine and essentially nothing else of concern. No tobacco leaf. No combustion. No smoke. No tar. No carbon monoxide. The ingredient list is nicotine, plant-based fibers, flavoring, sweeteners, and pH adjusters. That’s fundamentally different from a cigarette.

So the question isn’t “are nicotine pouches as dangerous as cigarettes?” They’re not. That’s established. The real question is “what are the risks of long-term oral nicotine exposure without tobacco or combustion?” And that’s more nuanced.

What the FDA Has Said

In 2019, the FDA authorized certain Swedish Match products (the company behind Zyn) as Modified Risk Tobacco Products (MRTPs). Specifically, this applied to their General snus products. The FDA determined that marketing these products as presenting lower risk than cigarettes was scientifically supported.

In 2024, Zyn pouches received premarket tobacco product authorization from the FDA, meaning the agency determined that their sale is “appropriate for the protection of public health.” This isn’t the same as calling them safe. It means the FDA concluded that allowing these products on the market benefits public health, largely because they give smokers a much less harmful alternative.

The FDA has been careful about its language. They haven’t said nicotine pouches are safe. They’ve said they’re significantly less harmful than cigarettes, and that making them available helps public health on balance. That’s a meaningful distinction. The FDA is acknowledging the harm reduction value while leaving room for the possibility that there are some long-term risks we haven’t fully characterized yet.

Swedish Snus: The Best Long-Term Data We Have

Here’s where we get lucky. Sweden has been using snus, which is a moist tobacco pouch placed under the lip, for over a century. Nicotine pouches aren’t identical to snus (snus contains actual tobacco while pouches don’t), but the nicotine delivery method is very similar: oral absorption through the gum lining.

Sweden has the lowest rate of smoking-related disease in Europe. Swedish men have the highest rate of tobacco use in Europe (when you include snus), but they have the lowest rates of lung cancer and cardiovascular disease among European males. This is a real-world, population-level dataset spanning decades.

Key findings from Swedish snus research:

Cancer risk. Multiple large studies have found no significant increase in oral cancer, lung cancer, or overall cancer risk among snus users compared to non-tobacco users. A major meta-analysis published in the International Journal of Cancer reviewed data from multiple Scandinavian cohort studies and found no statistically significant link between snus use and cancer.

Cardiovascular risk. The data here is slightly more complex. Some studies have found a small increase in cardiovascular mortality among snus users, particularly related to heart failure and type 2 diabetes risk. However, other large studies have found no significant cardiovascular risk increase. The overall picture is that if there is a cardiovascular risk from snus, it’s small compared to smoking, which roughly doubles your cardiovascular disease risk.

Oral health. Snus users do show higher rates of gingival recession (receding gums) at the site where they typically place the snus. This is a localized effect. It’s not dangerous in most cases, but it’s real. Nicotine pouch users may experience similar localized gum effects, though pouches are generally smaller and may cause less irritation than traditional snus.

Pancreatic cancer. This is the one area where some studies have found a possible association with snus use. A few Scandinavian studies found a slightly elevated risk of pancreatic cancer among heavy, long-term snus users. However, the results haven’t been consistent across studies, and the absolute risk increase, if real, is small. This remains an area of active research.

Now, here’s the important caveat: nicotine pouches are not snus. Snus contains real tobacco leaf, which means it contains tobacco-specific nitrosamines (TSNAs), which are known carcinogens. The levels in snus are much lower than in cigarette smoke, but they’re present.

Nicotine pouches contain either pharmaceutical-grade nicotine derived from tobacco or, in some cases, synthetic nicotine. They don’t contain tobacco leaf, so TSNA levels should be dramatically lower or essentially absent. This means nicotine pouches are likely somewhat safer than even snus. But we don’t have the multi-decade population data on pouches specifically to confirm this.

What We Know About Nicotine Itself

Since nicotine pouches are essentially a clean nicotine delivery system, the long-term risk question boils down significantly to: what does chronic nicotine exposure do to the body?

Cardiovascular effects. Nicotine is a stimulant. It acutely raises heart rate and blood pressure. Chronic nicotine use can contribute to arterial stiffness over time. For people with existing cardiovascular disease, this isn’t trivial. However, the cardiovascular harm from nicotine alone is a fraction of the harm from smoking, which causes cardiovascular damage through carbon monoxide exposure, oxidative stress from smoke particles, and inflammation.

Addiction. Nicotine is addictive. Long-term pouch use will maintain nicotine dependence. This is a real consideration. You’re not smoking, which is great, but you are dependent on a substance. Whether that matters to you is a personal call. Many people view lifelong nicotine pouch use similar to lifelong coffee use. It’s a dependency, but is it actually causing harm?

Brain development. Nicotine can harm developing brains. This is relevant for adolescents and young adults, and for pregnant women. If you’re an adult who smoked for years and switched to pouches, this isn’t your concern. But it’s worth noting because nicotine pouches have become popular among younger demographics who never smoked, which is a different risk-benefit equation.

Insulin resistance. Some research suggests chronic nicotine exposure may affect insulin sensitivity. This could theoretically increase type 2 diabetes risk. The evidence is mixed and the effect size is small, but it’s something researchers are watching.

Gastrointestinal effects. Nicotine stimulates gastric acid production and can worsen acid reflux. For long-term users, this may be relevant if you’re prone to GERD or ulcers.

What We Genuinely Don’t Know

Honesty time. Here are the gaps in our knowledge:

We don’t have 20-year pouch-specific studies. Modern nicotine pouches have only been widely available since the late 2010s. We can extrapolate from snus data and nicotine research, but pouch-specific long-term outcome data simply doesn’t exist yet.

We don’t fully understand the oral health effects. We know snus can cause gum recession. Do pouches cause the same thing? Probably to some degree, but the extent isn’t well characterized. The pouches are different in composition and size, so the effect might be different.

We don’t know the effects of long-term flavoring exposure. Nicotine pouches contain food-grade flavorings that are generally recognized as safe for ingestion. But “safe to eat” and “safe to hold against your gum tissue for hours daily for years” might not be the same thing. This isn’t a reason to panic. It’s just a genuine unknown.

We don’t know if the nicotine extraction and purification process introduces any relevant contaminants. Manufacturers say no, and testing of major brands hasn’t revealed concerning contaminants, but independent long-term monitoring is still limited.

We don’t know population-level effects. If nicotine pouches dramatically reduce smoking rates (as snus did in Sweden), the net public health benefit could be enormous even if pouches carry some small risk. But if pouches primarily attract new nicotine users who wouldn’t have smoked, the calculus changes.

The Relative Risk Framework

Here’s how I think about it, and how most harm reduction experts frame it:

If smoking is a 100 on the risk scale, nicotine pouches are somewhere between 2 and 10. Nobody credible puts them anywhere near smoking. The argument among scientists is whether they’re 95% less harmful or 98% less harmful. That’s the range of the debate.

For context, other common risk comparisons:

Smoking: 100
Smokeless tobacco (chew/dip): roughly 10-20
Swedish snus: roughly 2-10
Nicotine pouches: likely similar to or lower than snus
NRT products (patches, gum): roughly 1-2
Not using nicotine at all: 0

Where nicotine pouches fall on this spectrum depends on factors we’re still researching. But they’re firmly in the “dramatically less harmful than smoking” category by any reasonable assessment.

Who Should Be Concerned

If you’re a current or recent smoker, the risk calculation is simple. Nicotine pouches are enormously safer than continuing to smoke. If pouches help you stay off cigarettes, use them. Worrying about potential long-term pouch risks while smoking a pack a day is like worrying about the calories in a life preserver while drowning.

If you’re pregnant or planning to become pregnant, nicotine in any form is inadvisable. Nicotine constricts blood vessels to the placenta and affects fetal development.

If you have serious cardiovascular disease (recent heart attack, unstable angina, serious arrhythmias), talk to your cardiologist. The stimulant effects of nicotine are relevant for you, even without the combustion products.

If you never smoked and are thinking about starting nicotine pouches, the risk-benefit analysis is entirely different. There’s no health benefit to starting nicotine use. Any risk, however small, is a net negative compared to not using nicotine at all.

If you’re a former smoker who’s been nicotine-free for years, starting pouches would be reintroducing an addictive substance with no clear benefit. That’s different from using pouches to get off cigarettes.

My Honest Take

Nicotine pouches are not risk-free. No nicotine product is. But the risks are in a completely different universe from smoking.

If I had to guess where the science will land in 20 years, based on the snus data, the nicotine research, and the product composition, I’d guess that long-term nicotine pouch use will be associated with some minor increase in gum recession, possibly a very small cardiovascular risk in susceptible individuals, and continued nicotine dependence. I don’t expect we’ll find cancer risk anywhere near smoking, because the carcinogenic components of smoking (combustion products, TSNAs in high quantities) are absent or present at trace levels in pouches.

But I could be wrong. That’s the nature of genuinely new products. The honest answer to “are nicotine pouches safe long term?” is “almost certainly far safer than smoking, probably comparable to snus, and we’ll know more in a decade.”

For now, if pouches are keeping you off cigarettes, the evidence overwhelmingly supports that you’re making a health-positive choice. If you’re uncomfortable with the unknowns, FDA-approved NRT products (patches, gum, lozenges) have the longest safety track record of any nicotine delivery system and are a solid alternative.

Don’t let perfect be the enemy of good. Getting off cigarettes is the single best thing you can do for your health. If nicotine pouches are how you get there, use them without guilt. And revisit the question in a few years as more research comes in.